These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36194187)

  • 41. Comparison of Symptom Control in Pediatric Gastroparesis Using Endoscopic Pyloric Botulinum Toxin Injection and Dilatation.
    Mercier C; Ley D; Aumar M; Lemale J; Fabre A; Colinet S; Duhamel A; Gottrand F
    J Pediatr Gastroenterol Nutr; 2021 Sep; 73(3):314-318. PubMed ID: 34091544
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevention of delayed gastric emptying after esophagectomy: a single center's experience with botulinum toxin.
    Martin JT; Federico JA; McKelvey AA; Kent MS; Fabian T
    Ann Thorac Surg; 2009 Jun; 87(6):1708-13; discussion 1713-4. PubMed ID: 19463583
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Botulinum toxin injections for adults with overactive bladder syndrome.
    Duthie JB; Vincent M; Herbison GP; Wilson DI; Wilson D
    Cochrane Database Syst Rev; 2011 Dec; (12):CD005493. PubMed ID: 22161392
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Botulinum toxin injections for adults with overactive bladder syndrome.
    Duthie J; Wilson DI; Herbison GP; Wilson D
    Cochrane Database Syst Rev; 2007 Jul; (3):CD005493. PubMed ID: 17636801
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combined use of botulinum toxin type A and B for forehead rhytides: a randomized, double-blind, split-face study.
    Choi JW; Youn CS; An HT; Yoo JY; Na JI; Park KC; Youn SW; Huh CH
    J Dermatolog Treat; 2013 Apr; 24(2):126-32. PubMed ID: 21801115
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Placebo controlled, randomised, double blind study of the effects of botulinum A toxin on detrusor sphincter dyssynergia in multiple sclerosis patients.
    Gallien P; Reymann JM; Amarenco G; Nicolas B; de Sèze M; Bellissant E
    J Neurol Neurosurg Psychiatry; 2005 Dec; 76(12):1670-6. PubMed ID: 16291892
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of botulinum toxin in pediatric spasticity (cerebral palsy).
    Berweck S; Heinen F
    Mov Disord; 2004 Mar; 19 Suppl 8():S162-7. PubMed ID: 15027070
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Botox: the poison that heals.
    Khanna S; Jain S
    Int Dent J; 2006 Dec; 56(6):356-8. PubMed ID: 17243469
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Letter to editor: Botulinum toxin-augmented surgery - another option for large-angle esodeviations.
    Eur J Ophthalmol; 2023 May; 33(3):NP153-NP154. PubMed ID: 36550786
    [No Abstract]   [Full Text] [Related]  

  • 50. Letter to editor: Botulinum toxin-augmented surgery - another option for large-angle esodeviations.
    Wan MJ; Chiu H; Shah AS; Hunter DG
    Eur J Ophthalmol; 2023 May; 33(3):NP152. PubMed ID: 36550783
    [No Abstract]   [Full Text] [Related]  

  • 51. Videofluoroscopy-guided botulinum toxin for pharyngoesophageal spasm: a promising advance in laryngectomy rehabilitation.
    Maniaci A; Lavalle S; Mayo-Yanez M; Parisi FM; Cocuzza S
    Eur Arch Otorhinolaryngol; 2024 Jun; 281(6):3305-3306. PubMed ID: 38456929
    [No Abstract]   [Full Text] [Related]  

  • 52. Botulinum Toxin Injection for Treatment of Gastroparesis.
    Pasricha TS; Pasricha PJ
    Gastrointest Endosc Clin N Am; 2019 Jan; 29(1):97-106. PubMed ID: 30396531
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Application of botulinum toxin to clinical therapy: advances and cautions.
    Levy NS; Lowenthal DT
    Am J Ther; 2012 Jul; 19(4):281-6. PubMed ID: 22481607
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gastroparesis in children.
    Islam S
    Curr Opin Pediatr; 2015 Jun; 27(3):377-82. PubMed ID: 25944312
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neurotoxins licensed as treatment for neck neuromuscular disorder.
    Am J Health Syst Pharm; 2001 Feb; 58(3):200, 202. PubMed ID: 11217174
    [No Abstract]   [Full Text] [Related]  

  • 56. Unlabeled uses of botulinum toxins: a review, part 1.
    Cheng CM; Chen JS; Patel RP
    Am J Health Syst Pharm; 2006 Jan; 63(2):145-52. PubMed ID: 16390928
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle.
    Miller LS; Szych GA; Kantor SB; Bromer MQ; Knight LC; Maurer AH; Fisher RS; Parkman HP
    Am J Gastroenterol; 2002 Jul; 97(7):1653-60. PubMed ID: 12135014
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Botulinum toxins types A and B for brow furrows: preliminary experiences with type B toxin dosing.
    Lowe NJ; Yamauchi PS; Lask GP; Patnaik R; Moore D
    J Cosmet Laser Ther; 2002 Mar; 4(1):15-8. PubMed ID: 12079632
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Investigational drug therapies for the treatment of gastroparesis.
    Sanger GJ; Pasricha PJ
    Expert Opin Investig Drugs; 2017 Mar; 26(3):331-342. PubMed ID: 28127997
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations.
    Bhidayasiri R; Cardoso F; Truong DD
    Eur J Neurol; 2006 Feb; 13 Suppl 1():21-9. PubMed ID: 16417594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.